University of Illinois at Chicago
Exemption #JJW1023

Announcement of an Exempt Purchase

Award Info Published Tuesday June 29, 2021

Optum Frontier Therapies LLCFlint, MI

  • Amount: An estimated $300,000
  • Terms: An estimated start date of 6/29/2021 through 6/30/2024
  • Renewals: None

Summary

Vendors

1 total
0 BEP vendors
0 VBP vendors
0 Small businesses

The University award process may be delayed up to thirty days as this award goes through a state approval process.

First published Tuesday, June 29, 2021
The University awarded a contract for prescription medicine.
Aubagio-A prescription medicine used to treat patients at UI Health who have relapsing forms of multiple sclerosis.
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) Aubagio-A is a prescription medicine used to treat patients at UI Health who have relapsing forms of multiple sclerosis. This is needed to treat patients of UI Health with the best therapies available.

For instructions on how to obtain a comprehensive purchase description, disclosure or contract forms, contact:
Jeffrey Walsh
University of Illinois at Chicago
Purchasing Division (M/C 560)
809 South Marshfield Avenue
Chicago, IL 60612-7203
Phone: (312) 355-3568
FAX: (312) 996-3135

The State of Illinois has a policy to encourage prospective vendors to hire qualified veterans, minorities, females, persons with disabilities and ex-offenders.

Documents

To obtain any of the following documents, please log into your Bulletin account.

Exemption Document

  • JJW1023OptumsignedExemption.pdf (2 MB)
Log In